Monoclonal antibodies help fight acute COVID-19. This therapy works best if administered as early as possible (within 10 days of onset of symptoms) and greatly reduces the risk of hospitalization for those at moderate-to-high risk. The team at St. Luke's Clinic – COVID Antibody Treatment administers Regeneron monoclonal antibody “Regen-CoV” therapy, which has been granted Emergency Use Authorization (EUA) approval from the FDA. Treatment or testing for this therapy is not available at St. Luke’s emergency departments.
The following medical conditions or other factors may place patients at higher risk for progression to severe COVID-19:
St. Luke's is prepared to support our patients and community as we enter the fall flu season with COVID-19 still spreading across Idaho. Our commitment to safe care includes coronavirus testing, visitor screening, enhanced safety practices and more.
With MyChart, you’re able to view test results, contact your provider, request medication refills, schedule appointments and more. We encourage you to sign up for easy access to the tools and information you need to proactively manage your health. You can also set up online proxy access requests for medical records of children, spouses, or dependents.
There's also an easy-to-use MyChart app available for your mobile devices!